Navigation Links
Aratana Therapeutics Reports Second Quarter 2013 Financial Results
Date:8/12/2013

KANSAS CITY, Kan. and BOSTON, Aug. 12, 2013 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX) today announced its financial results for the second quarter of 2013, product development updates and the continued build-out of its pipeline.

For the quarter ended June 30, 2013, the Company reported a net loss of $4.2 million, or $(4.62) per share, compared with a net loss of $3.1 million, or $(10.21) per share for the quarter ended June 30, 2012. For the six months ended June 30, 2013, the Company reported a net loss of $8.3 million, or $(9.35) per share, compared with a net loss of $5.8 million, or $(19.15) per share for the six months ended June 30, 2012.

As of June 30, 2013, the Company had a total of approximately $20.2 million in cash, cash equivalents and marketable securities.
This number reflects the prepayment in June of $2.7 million of expenses related to the Company's initial public offering. In July, the Company completed the initial public offering which, together with the exercise of the underwriters' overallotment, provided $34.2 million in net proceeds. The Company's total cash and cash equivalents post-IPO was approximately $57.1 million.

"We are aggressively moving forward following our recent IPO with a sharp focus on our clinical programs and expanding our product pipeline," said Dr. Steven St. Peter, President and CEO of Aratana Therapeutics.  "We are pleased to share details on our progress and plans for the future."

Development Programs and Upcoming Milestones

  • AT-001 Dog: Completed enrollment in dose-ranging field study; results expected in November 2013; anticipate U.S. approval in 2016
  • AT-001 Cat: Anticipate initiating additional proof of concept study this month; results expected in November 2013
  • AT-002 Dog: Continuing discussion with the Center for Veterinary Medicine (CVM) to gain concur
    '/>"/>

  • SOURCE Aratana Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Aratana to Participate in Leerink Swanns November Management Access Days
    2. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
    3. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
    4. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
    5. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
    6. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
    7. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
    8. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
    9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    11. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... China, Dec. 24, 2014 /PRNewswire/  -- Tianyin Pharmaceutical ... pharmaceutical company that specializes in the patented biopharmaceutical, ... active pharmaceutical ingredients (API) released unaudited preliminary financial ... 2015. Fiscal Year 2015 Ended September ... $9.7 million compared with $14.7 million in 1Q14 ...
    (Date:12/24/2014)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ), ... announce Jennifer Hagerman , Pharm.D., AE-C, senior director ... as the president of the Michigan Pharmacists Association on ... place Feb. 28, 2015, at the MPA Annual Convention ... Center in Detroit, Michigan . Hagerman ...
    (Date:12/24/2014)... 2014  Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), ... the development of brachytherapy devices and medical isotopes ... it has filed a de novo ... for marketing clearance for its patented Y-90 RadioGel(TM) ... Food, Drug and Cosmetic Act (the "Act").  ...
    Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
    ... YORK, Aug. 11, 2011 Reportlinker.com announces ... is available in its catalogue: ... Health Global Overview 2011 ... Generic drugs are usually associated with ...
    ... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced ... Savient will present at the Wedbush Securities 2011 Life Sciences ... p.m. Eastern Time.  The conference will be held at Le ... A live webcast of the presentation can be accessed through ...
    Cached Medicine Technology:Generic Drugs in Consumer Health Global Overview 2011 2
    (Date:12/26/2014)... India Network Foundation, a non-profit US based ... today a new version of “ EasySelect ”, a ... plan for their visiting parents. The technology tool is ... process when choosing an insurance plan by showing the ... few clicks. Many elderly Asian Indian parents often find ...
    (Date:12/26/2014)... 26, 2014 DW-InductionHeating.com (DaWei Induction Heating ... researching and developing, producing and marketing of a series ... business announces their new series of induction brazing ... the company, induction brazing refers to the ... filler material and heat. The manager says that there ...
    (Date:12/25/2014)... The microscopy market is estimated to ... $5,756.0 million by 2019. Optical microscopy is the ... microscopes product segment is expected to show the ... focus on nanotechnology, technological advancements, and increasing federal ... , Get Full Copy of Report @ ...
    (Date:12/25/2014)... 26, 2014 The click ... beauty, strength and durability. Today, the business announces ... is valid until Jan. 30, 2015. , Click ... traditional hardwood. BambooFlooringChina.com is a well-known brand in ... worldwide to find a reliable bamboo flooring supplier. ...
    (Date:12/25/2014)... December 26, 2014 The report “TS-1 ... focuses on the current treatment landscape, unmet needs, current ... TS-1 is an anti-cancer drug which is typically used ... is also used for treating gastric cancer and pancreatic ... potassium. The drug was first approved in 1999 in ...
    Breaking Medicine News(10 mins):Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
    ... night time have a higher risk of early infant ... Previous studies have also shown that infants born at ... risk of death at birth, urging the need for ... neonatal care during the night. Researchers conducted a population ...
    ... known to help people protect themselves against Alzheimer's disease. Now, ... reason as to why this might be so. These scientists ... used to detect the presence of plaque. Plaque is a ... the// Alzheimer's disease. The researchers have now used this marker ...
    ... blood vessels in the brain, causing the vessel to bulge, ... on an average, suffer a brain hemorrhage in a year ... size of the neck of the bulge. A bulge with ... lots of tiny metal coils that divert blood flow away ...
    ... in Boston and the University of Michigan School of Dentistry ... Microbiology that bad breath or halitosis is caused by certain ... top of your tongue. The study was based on gene ... with halitosis and those with fresh breath. Researchers found species ...
    ... The New Scientist magazine in its January issue has reported that ... high in fat and calories may be addictive. The researchers have ... a lack of self-control, but is most likely due to the ... could impair the ability to control eating. As people start gaining ...
    ... US study has shown that those people who eat breakfast ... disease. The researchers found from the Children’s Hospital in Boston ... 35-50 per cent lower among people who ate breakfast compared ... day. Insulin resistance syndrome is a disorder that includes// obesity, ...
    Cached Medicine News:Health News:Germs to blame for bad breath 2
    ... simple to operate fluid warmer designed to provide ... blood or other fluids being transfused to a ... reservoir which is heated by two 150-watt heaters ... up by a thermoswitch. Blood is warmed to ...
    Are you looking for an inexpensive, effective Blood and Infusion Warmer? , ,Animec is an economical fluid warmer that uses standard I.V. tubing instead of special disposable sets....
    ... The complete anesthesia solution for the MRI environment ... Environment , ,The Narkomed MRI-2 is ... and VPO monitor, designed and engineered to perform, ... unshielded MRI environments of up to 3.0 Tesla. ...
    ... rugged and easy-to-use solution that's perfectly suited ... ,Symeon's light weight and mobility mean ... any working position. It can also be ... cable "spaghetti syndrome" is minimized through the ...
    Medicine Products: